Mechanism of troxerutin-mediated regulation of EGLN3/LRPPRC in B[a]P-induced lung adenocarcinoma.

Wu Y, Wang J, Xing Y, Gu Y

Open source

DOI
10.1016/j.intimp.2026.117242
Published
2026 Oct 15
Container
International immunopharmacology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117242,
  title = {Mechanism of troxerutin-mediated regulation of EGLN3/LRPPRC in B[a]P-induced lung adenocarcinoma.},
  author = {Wu Y and Wang J and Xing Y and Gu Y},
  year = {2026},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2026.117242},
  url = {https://doi.org/10.1016/j.intimp.2026.117242}
}

RIS

TY  - JOUR
TI  - Mechanism of troxerutin-mediated regulation of EGLN3/LRPPRC in B[a]P-induced lung adenocarcinoma.
AU  - Wu Y
AU  - Wang J
AU  - Xing Y
AU  - Gu Y
PY  - 2026
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2026.117242
UR  - https://doi.org/10.1016/j.intimp.2026.117242
ER  - 

APA

Y, W., J, W., Y, X., & Y, G. (2026). Mechanism of troxerutin-mediated regulation of EGLN3/LRPPRC in B[a]P-induced lung adenocarcinoma.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117242

Source records